HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tailored approach to the treatment of vernal keratoconjunctivitis.

AbstractPURPOSE:
To develop a standardized clinical grading system for the management of patients with vernal keratoconjunctivitis (VKC) and to identify the risk factors associated with a worsened outcome of the disease, including decrease of visual acuity and ocular complications development.
DESIGN:
Retrospective cohort study.
PARTICIPANTS:
A total of 207 consecutive patients with VKC, referred to our Cornea and External Diseases Center from 1997 to 2007, were included in the study. A total of 110 of those patients were included in the follow-up study (range 1-10 years).
METHODS:
Classification and regression tree (CART) analysis was performed to separate the patients into 5 subgroups by therapeutic approach. Regression tree and multivariate logistic regression analyses were performed during follow-up to identify predictors of worse visual outcome.
MAIN OUTCOME MEASURES:
Age, gender, duration and course of disease, signs, symptoms, overall symptoms score, history of atopy, markers of allergy, best-corrected visual acuity, and therapy were collected at baseline and during follow-up. The number of relapses and number of patients with decreased visual acuity were also evaluated in the follow-up.
RESULTS:
A decision tree for VKC treatment was developed by CART analysis, and a new clinical grading system was proposed accordingly. Sixteen patients were classified as grade 0 (absence of symptoms and no therapy); 59 patients were classified as grade 1 (presence of symptoms without photophobia, occasional use of anti-allergic eye drop); 74 patients were classified as grade 2 (presence of symptoms including photophobia, daily anti-allergic treatment); 22 patients with superficial punctuate keratopathy (SPK) were classified as grade 3 (daily anti-allergic treatment associated with occasional topical steroid); and 36 patients were classified as grade 4 (diffuse SPK or corneal ulcer; pulsed high-dose topical steroid). A higher number of relapses and a higher baseline grade of VKC were the main predictor factors for worse visual outcome.
CONCLUSIONS:
This grading system allows for identifying the more severe forms of VKC that are at higher risk of recurrences, corneal ulceration, and worse final visual outcome.
FINANCIAL DISCLOSURE(S):
The author(s) have no proprietary or commercial interest in any materials discussed in this article.
AuthorsMarta Sacchetti, Alessandro Lambiase, Flavio Mantelli, Velika Deligianni, Andrea Leonardi, Stefano Bonini
JournalOphthalmology (Ophthalmology) Vol. 117 Issue 7 Pg. 1294-9 (Jul 2010) ISSN: 1549-4713 [Electronic] United States
PMID20382430 (Publication Type: Journal Article)
CopyrightCopyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Allergic Agents
  • Glucocorticoids
Topics
  • Adolescent
  • Adult
  • Anti-Allergic Agents (therapeutic use)
  • Child
  • Child, Preschool
  • Conjunctivitis, Allergic (classification, drug therapy, physiopathology)
  • Decision Trees
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids (therapeutic use)
  • Humans
  • Male
  • Multivariate Analysis
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: